Septerna, Inc.

NEWS

Business

Top Life Sciences Startups to Watch in 2023

BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.

December 5, 2022

15 min read

BioSpace Editorial Staff

Biotech Bay

Genetown and Biotech Bay Reel in Series A Funds in 2022

After reaching a record high in 2021, venture capital dollars have tailed off in the biopharma industry in 2022. That said, a few biopharma hotbeds have still seen sizeable launch rounds.

November 2, 2022

5 min read

Heather McKenzie

IN THE PRESS

Press Releases

Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist

February 18, 2025

6 min read

Press Releases

Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer

January 6, 2025

3 min read

Press Releases

Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 18, 2024

1 min read

Press Releases

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

November 20, 2024

10 min read

Press Releases

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

October 31, 2024

2 min read

Press Releases

Septerna Prices Upsized Initial Public Offering

October 25, 2024

4 min read

Press Releases

Septerna Presents New Preclinical Data at ASBMR 2024 Highlighting Therapeutic Potential of Oral Small Molecule Parathyroid Hormone 1 Receptor (PTH1R) Agonists for Hypoparathyroidism

September 30, 2024

3 min read

Biotech Bay

Septerna to Participate in the Jefferies Global Healthcare Conference

May 28, 2024

1 min read

Biotech Bay

Septerna to Present Preclinical Data from GPCR Drug Discovery Engine at ENDO 2024

May 20, 2024

4 min read

Biotech Bay

Septerna to Participate in Upcoming Investor and Industry Conferences

February 22, 2024

1 min read

AWARDS

JOBS